Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 22, Number 3—March 2016

Volume 22, Number 3—March 2016   PDF Version [PDF - 9.09 MB - 224 pages]

Perspective

  • Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease PDF Version [PDF - 500 KB - 5 pages]
    R. M. Raju et al.
    View Summary

    Recent advances in TB diagnosis and treatment must be considered in the basic scientific research of other mycobacterial diseases.

        View Abstract

    The nontuberculous mycobacteria (NTM), defined as any mycobacterial pathogen other than Mycobacterium tuberculosis or Mycobacterium leprae, are a diverse group of pathogens that collectively cause a substantive but often unappreciated worldwide burden of illness. Although NTMs may cause illness similar to M. tuberculosis, these pathogens generally do not respond to classic tuberculosis (TB) drug regimens, resulting in misdiagnosis and poor treatment, particularly in resource-poor settings. Although a few high-quality epidemiologic surveys have been made on the topic, existing evidence suggests that NTM-associated disease is much more common than previously thought: more common than TB in the industrialized world and likely increasing in prevalence globally. Despite this evidence, these organisms remain markedly understudied, and few international grants support basic science and clinical research. Here we suggest that the considerable efforts in developing new treatments and diagnostics for TB can be harnessed in the fight against NTM-associated illnesses.

        Cite This Article
    EID Raju RM, Raju SM, Zhao Y, Rubin EJ. Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerg Infect Dis. 2016;22(3):365-369. https://dx.doi.org/10.3201/eid2203.151643
    AMA Raju RM, Raju SM, Zhao Y, et al. Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerging Infectious Diseases. 2016;22(3):365-369. doi:10.3201/eid2203.151643.
    APA Raju, R. M., Raju, S. M., Zhao, Y., & Rubin, E. J. (2016). Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerging Infectious Diseases, 22(3), 365-369. https://dx.doi.org/10.3201/eid2203.151643.
        Email Email this Article

Synopses

  • Medscape CME Activity
    Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013 PDF Version [PDF - 702 KB - 9 pages]
    K. Benedict and R. K. Mody
    View Summary

    Continued occurrence, particularly in work-related settings, highlights the need to increase awareness of this disease.

        View Abstract

    Histoplasmosis has been described as the most common endemic mycosis in the United States. However, histoplasmosis is not nationally notifiable. Its presumed geographic distribution is largely derived from skin test surveys performed during the 1940s, and information about its local features comes primarily from outbreak investigations. We conducted a literature review to assess epidemiologic features of histoplasmosis outbreaks in the United States. During 1938–2013, a total of 105 outbreaks involving 2,850 cases were reported in 26 states and the territory of Puerto Rico. Common exposure settings were chicken coops and buildings or other structures undergoing renovation or demolition. Birds, bats, or their droppings were reported to be present in 77% of outbreak settings, and workplace exposures were reported in 41% of outbreaks. The continued occurrence of histoplasmosis outbreaks, particularly work-related ones involving known disturbance of bird or bat droppings, highlights the need to increase awareness of the disease.

        Cite This Article
    EID Benedict K, Mody RK. Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013. Emerg Infect Dis. 2016;22(3):370-378. https://dx.doi.org/10.3201/eid2203.151117
    AMA Benedict K, Mody RK. Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013. Emerging Infectious Diseases. 2016;22(3):370-378. doi:10.3201/eid2203.151117.
    APA Benedict, K., & Mody, R. K. (2016). Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013. Emerging Infectious Diseases, 22(3), 370-378. https://dx.doi.org/10.3201/eid2203.151117.
        Email Email this Article
  • Avian Influenza A(H5N1) Virus in Egypt PDF Version [PDF - 854 KB - 10 pages]
    G. Kayali et al.
    View Summary

    An aggressive plan to curb these infections in poultry is urgently needed.

        View Abstract

    In Egypt, avian influenza A subtype H5N1 and H9N2 viruses are enzootic in poultry. The control plan devised by veterinary authorities in Egypt to prevent infections in poultry focused mainly on vaccination and ultimately failed. Recently, widespread H5N1 infections in poultry and a substantial increase in the number of human cases of H5N1 infection were observed. We summarize surveillance data from 2009 through 2014 and show that avian influenza viruses are established in poultry in Egypt and are continuously evolving genetically and antigenically. We also discuss the epidemiology of human infection with avian influenza in Egypt and describe how the true burden of disease is underestimated. We discuss the failures of relying on vaccinating poultry as the sole intervention tool. We conclude by highlighting the key components that need to be included in a new strategy to control avian influenza infections in poultry and humans in Egypt.

        Cite This Article
    EID Kayali G, Kandeil A, El-Shesheny R, Kayed AS, Maatouq AM, Cai Z, et al. Avian Influenza A(H5N1) Virus in Egypt. Emerg Infect Dis. 2016;22(3):379-388. https://dx.doi.org/10.3201/eid2203.150593
    AMA Kayali G, Kandeil A, El-Shesheny R, et al. Avian Influenza A(H5N1) Virus in Egypt. Emerging Infectious Diseases. 2016;22(3):379-388. doi:10.3201/eid2203.150593.
    APA Kayali, G., Kandeil, A., El-Shesheny, R., Kayed, A. S., Maatouq, A. M., Cai, Z....Ali, M. A. (2016). Avian Influenza A(H5N1) Virus in Egypt. Emerging Infectious Diseases, 22(3), 379-388. https://dx.doi.org/10.3201/eid2203.150593.
        Email Email this Article
  • Medscape CME Activity
    Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation PDF Version [PDF - 541 KB - 7 pages]
    V. K. Phadke et al.
    View Summary

    As more of these devices are implanted, such infections are likely to be more frequently reported.

        View Abstract

    Mycobacterial infections resulting from cardiac implantable electronic devices are rare, but as more devices are implanted, these organisms are increasingly emerging as causes of early-onset infections. We report a patient with an implantable cardioverter-defibrillator pocket and associated bloodstream infection caused by an organism of the Mycobacterium fortuitum group, and we review the literature regarding mycobacterial infections resulting from cardiac device implantations. Thirty-two such infections have been previously described; most (70%) were caused by rapidly growing species, of which M. fortuitum group species were predominant. When managing such infections, clinicians should consider the potential need for extended incubation of routine cultures or dedicated mycobacterial cultures for accurate diagnosis; combination antimicrobial drug therapy, even for isolates that appear to be macrolide susceptible, because of the potential for inducible resistance to this drug class; and the arrhythmogenicity of the antimicrobial drugs traditionally recommended for infections caused by these organisms.

        Cite This Article
    EID Phadke VK, Hirsh DS, Goswami ND. Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation. Emerg Infect Dis. 2016;22(3):389-395. https://dx.doi.org/10.3201/eid2203.150584
    AMA Phadke VK, Hirsh DS, Goswami ND. Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation. Emerging Infectious Diseases. 2016;22(3):389-395. doi:10.3201/eid2203.150584.
    APA Phadke, V. K., Hirsh, D. S., & Goswami, N. D. (2016). Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation. Emerging Infectious Diseases, 22(3), 389-395. https://dx.doi.org/10.3201/eid2203.150584.
        Email Email this Article
  • Medscape CME Activity
    Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013 PDF Version [PDF - 618 KB - 8 pages]
    A. Sharma et al.
    View Summary

    Routine reporting of TB caused by this organism does not appear warranted at this time.

        View Abstract

    Mycobacterium africanum is endemic to West Africa and causes tuberculosis (TB). We reviewed reported cases of TB in the United States during 2004–2013 that had lineage assigned by genotype (spoligotype and mycobacterial interspersed repetitive unit variable number tandem repeats). M. africanum caused 315 (0.4%) of 73,290 TB cases with lineage assigned by genotype. TB caused by M. africanum was associated more with persons from West Africa (adjusted odds ratio [aOR] 253.8, 95% CI 59.9–1,076.1) and US-born black persons (aOR 5.7, 95% CI 1.2–25.9) than with US-born white persons. TB caused by M. africanum did not show differences in clinical characteristics when compared with TB caused by M. tuberculosis. Clustered cases defined as >2 cases in a county with identical 24-locus mycobacterial interspersed repetitive unit genotypes, were less likely for M. africanum (aOR 0.1, 95% CI 0.1–0.4), which suggests that M. africanum is not commonly transmitted in the United States.

        Cite This Article
    EID Sharma A, Bloss E, Heilig CM, Click ES. Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013. Emerg Infect Dis. 2016;22(3):396-403. https://dx.doi.org/10.3201/eid2203.151505
    AMA Sharma A, Bloss E, Heilig CM, et al. Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013. Emerging Infectious Diseases. 2016;22(3):396-403. doi:10.3201/eid2203.151505.
    APA Sharma, A., Bloss, E., Heilig, C. M., & Click, E. S. (2016). Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013. Emerging Infectious Diseases, 22(3), 396-403. https://dx.doi.org/10.3201/eid2203.151505.
        Email Email this Article
  • Methylotroph Infections and Chronic Granulomatous Disease PDF Version [PDF - 431 KB - 6 pages]
    E. Falcone et al.
    View Summary

    Disease caused by these environmental bacteria is almost exclusively limited to patients with this condition.

        View Abstract

    Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by a defect in production of phagocyte-derived reactive oxygen species, which leads to recurrent infections with a characteristic group of pathogens not previously known to include methylotrophs. Methylotrophs are versatile environmental bacteria that can use single-carbon organic compounds as their sole source of energy; they rarely cause disease in immunocompetent persons. We have identified 12 infections with methylotrophs (5 reported here, 7 previously reported) in patients with CGD. Methylotrophs identified were Granulibacter bethesdensis (9 cases), Acidomonas methanolica (2 cases), and Methylobacterium lusitanum (1 case). Two patients in Europe died; the other 10, from North and Central America, recovered after prolonged courses of antimicrobial drug therapy and, for some, surgery. Methylotrophs are emerging as disease-causing organisms in patients with CGD. For all patients, sequencing of the 16S rRNA gene was required for correct diagnosis. Geographic origin of the methylotroph strain may affect clinical management and prognosis.

        Cite This Article
    EID Falcone E, Petts JR, Fasano M, Ford B, Nauseef WM, Neves J, et al. Methylotroph Infections and Chronic Granulomatous Disease. Emerg Infect Dis. 2016;22(3):404-409. https://dx.doi.org/10.3201/eid2203.151265
    AMA Falcone E, Petts JR, Fasano M, et al. Methylotroph Infections and Chronic Granulomatous Disease. Emerging Infectious Diseases. 2016;22(3):404-409. doi:10.3201/eid2203.151265.
    APA Falcone, E., Petts, J. R., Fasano, M., Ford, B., Nauseef, W. M., Neves, J....Holland, S. M. (2016). Methylotroph Infections and Chronic Granulomatous Disease. Emerging Infectious Diseases, 22(3), 404-409. https://dx.doi.org/10.3201/eid2203.151265.
        Email Email this Article

Research

  • Mortality Rates during Cholera Epidemic, Haiti, 2010–2011 PDF Version [PDF - 373 KB - 7 pages]
    F. J. Luquero et al.
    View Summary

    Actual rates were higher than rates calculated from healthcare facility reports.

        View Abstract

    The 2010 cholera epidemic in Haiti was one of the largest cholera epidemics ever recorded. To estimate the magnitude of the death toll during the first wave of the epidemic, we retrospectively conducted surveys at 4 sites in the northern part of Haiti. Overall, 70,903 participants were included; at all sites, the crude mortality rates (19.1–35.4 deaths/1,000 person-years) were higher than the expected baseline mortality rate for Haiti (9 deaths/1,000 person-years). This finding represents an excess of 3,406 deaths (2.9-fold increase) for the 4.4% of the Haiti population covered by these surveys, suggesting a substantially higher cholera mortality rate than previously reported.

        Cite This Article
    EID Luquero FJ, Rondy M, Boncy J, Munger A, Mekaoui H, Rymshaw E, et al. Mortality Rates during Cholera Epidemic, Haiti, 2010–2011. Emerg Infect Dis. 2016;22(3):410-416. https://dx.doi.org/10.3201/eid2203.141970
    AMA Luquero FJ, Rondy M, Boncy J, et al. Mortality Rates during Cholera Epidemic, Haiti, 2010–2011. Emerging Infectious Diseases. 2016;22(3):410-416. doi:10.3201/eid2203.141970.
    APA Luquero, F. J., Rondy, M., Boncy, J., Munger, A., Mekaoui, H., Rymshaw, E....Ciglenecki, I. (2016). Mortality Rates during Cholera Epidemic, Haiti, 2010–2011. Emerging Infectious Diseases, 22(3), 410-416. https://dx.doi.org/10.3201/eid2203.141970.
        Email Email this Article
  • Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States PDF Version [PDF - 506 KB - 9 pages]
    C. A. Tschampl et al.
    View Summary

    Scale up of such services is possible and encouraged because of potential health gains and reduced healthcare costs.

        View Abstract

    A major problem resulting from interrupted tuberculosis (TB) treatment is the development of drug-resistant TB, including multidrug-resistant TB (MDR TB), a more deadly and costly-to-treat form of the disease. Global health systems are not equipped to diagnose and treat the current burden of MDR TB. TB-infected foreign visitors and temporary US residents who leave the country during treatment can experience treatment interruption and, thus, are at greater risk for drug-resistant TB. Using epidemiologic and demographic data, we estimated TB incidence among this group, as well as the proportion of patients referred to transnational care–continuity and management services during relocation; each year, ≈2,827 visitors and temporary residents are at risk for TB treatment interruption, 222 (8%) of whom are referred for transnational services. Scale up of transnational services for persons at high risk for treatment interruption is possible and encouraged because of potential health gains and reductions in healthcare costs for the United States and receiving countries.

        Cite This Article
    EID Tschampl CA, Garnick DW, Zuroweste E, Razavi M, Shepard DS. Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States. Emerg Infect Dis. 2016;22(3):417-425. https://dx.doi.org/10.3201/eid2203.141971
    AMA Tschampl CA, Garnick DW, Zuroweste E, et al. Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States. Emerging Infectious Diseases. 2016;22(3):417-425. doi:10.3201/eid2203.141971.
    APA Tschampl, C. A., Garnick, D. W., Zuroweste, E., Razavi, M., & Shepard, D. S. (2016). Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States. Emerging Infectious Diseases, 22(3), 417-425. https://dx.doi.org/10.3201/eid2203.141971.
        Email Email this Article
  • Encephalitis, Ontario, Canada, 2002–2013 PDF Version [PDF - 592 KB - 7 pages]
    A. S. Parpia et al.
    View Summary

    The epidemiology of encephalitis in Ontario is remarkably similar to that in England.

        View Abstract

    Encephalitis, a brain inflammation leading to severe illness and often death, is caused by >100 pathogens. To assess the incidence and trends of encephalitis in Ontario, Canada, we obtained data on 6,463 Ontario encephalitis hospitalizations from the hospital Discharge Abstract Database for April 2002–December 2013 and analyzed these data using multiple negative binomial regression. The estimated crude incidence of all-cause encephalitis in Ontario was ≈4.3 cases/100,000 persons/year. Incidence rates for infants <1 year of age and adults >65 years were 3.9 and 3.0 times that of adults 20–44 years of age, respectively. Incidence peaks during August–September in 2002 and 2012 resulted primarily from encephalitis of unknown cause and viral encephalitis. Encephalitis occurred more frequently in older age groups and less frequently in women in Ontario when compared to England, but despite differences in population, vector-borne diseases, climate, and geography, the epidemiology was overall remarkably similar in the two regions.

        Cite This Article
    EID Parpia AS, Li Y, Chen C, Dhar B, Crowcroft NS. Encephalitis, Ontario, Canada, 2002–2013. Emerg Infect Dis. 2016;22(3):426-432. https://dx.doi.org/10.3201/eid2203.151545
    AMA Parpia AS, Li Y, Chen C, et al. Encephalitis, Ontario, Canada, 2002–2013. Emerging Infectious Diseases. 2016;22(3):426-432. doi:10.3201/eid2203.151545.
    APA Parpia, A. S., Li, Y., Chen, C., Dhar, B., & Crowcroft, N. S. (2016). Encephalitis, Ontario, Canada, 2002–2013. Emerging Infectious Diseases, 22(3), 426-432. https://dx.doi.org/10.3201/eid2203.151545.
        Email Email this Article
  • Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa PDF Version [PDF - 647 KB - 9 pages]
    A. S. Parpia et al.
    View Summary

    Reduced access to healthcare during the outbreak substantially increased mortality rates from other diseases.

        View Abstract

    Response to the 2014–2015 Ebola outbreak in West Africa overwhelmed the healthcare systems of Guinea, Liberia, and Sierra Leone, reducing access to health services for diagnosis and treatment for the major diseases that are endemic to the region: malaria, HIV/AIDS, and tuberculosis. To estimate the repercussions of the Ebola outbreak on the populations at risk for these diseases, we developed computational models for disease transmission and infection progression. We estimated that a 50% reduction in access to healthcare services during the Ebola outbreak exacerbated malaria, HIV/AIDS, and tuberculosis mortality rates by additional death counts of 6,269 (2,564–12,407) in Guinea; 1,535 (522–2,8780) in Liberia; and 2,819 (844–4,844) in Sierra Leone. The 2014–2015 Ebola outbreak was catastrophic in these countries, and its indirect impact of increasing the mortality rates of other diseases was also substantial.

        Cite This Article
    EID Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis. 2016;22(3):433-441. https://dx.doi.org/10.3201/eid2203.150977
    AMA Parpia AS, Ndeffo-Mbah ML, Wenzel NS, et al. Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerging Infectious Diseases. 2016;22(3):433-441. doi:10.3201/eid2203.150977.
    APA Parpia, A. S., Ndeffo-Mbah, M. L., Wenzel, N. S., & Galvani, A. P. (2016). Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerging Infectious Diseases, 22(3), 433-441. https://dx.doi.org/10.3201/eid2203.150977.
        Email Email this Article
  • Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000–2012 PDF Version [PDF - 510 KB - 6 pages]
    P. K. Cassiday et al.
    View Summary

    These changes are concurrrent with other recent molecular changes and may be contributing to US pertussis reemergence.

        View Abstract

    To clarify the characteristics of circulating Bordetella pertussis isolates, we used pulsed-field gel electrophoresis (PFGE) to analyze 5,262 isolates collected in the United States during 2000–2012. We found 199 PFGE profiles; 5 profiles accounted for 72% of isolates. The most common profile, CDC013, accounted for 35%–46% of isolates tested from 2000–2009; however, the proportion of isolates of this profile rapidly decreased in 2010. Profile CDC237, first seen in 2009, increased rapidly and accounted for 29% of 2012 isolates. No location bias was observed among profiles during 2000–2010, but differences were observed among isolates from different states during 2012. Predominant profiles match those observed in recent European PFGE studies. PFGE profile changes are concurrent with other recent molecular changes in B. pertussis and may be contributing to the reemergence of pertussis in the United States. Continued PFGE monitoring is critical for understanding the changing epidemiology of pertussis.

        Cite This Article
    EID Cassiday PK, Skoff TH, Jawahir S, Tondella M. Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000–2012. Emerg Infect Dis. 2016;22(3):442-448. https://dx.doi.org/10.3201/eid2203.151136
    AMA Cassiday PK, Skoff TH, Jawahir S, et al. Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000–2012. Emerging Infectious Diseases. 2016;22(3):442-448. doi:10.3201/eid2203.151136.
    APA Cassiday, P. K., Skoff, T. H., Jawahir, S., & Tondella, M. (2016). Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000–2012. Emerging Infectious Diseases, 22(3), 442-448. https://dx.doi.org/10.3201/eid2203.151136.
        Email Email this Article
  • Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication PDF Version [PDF - 615 KB - 8 pages]
    I. M. Blake et al.
    View Summary

    Identification of spatiotemporal clustering of acute flaccid paralysis cases can accelerate outbreak detection and thereby support rapid response activities.

        View Abstract

    As the global eradication of poliomyelitis approaches the final stages, prompt detection of new outbreaks is critical to enable a fast and effective outbreak response. Surveillance relies on reporting of acute flaccid paralysis (AFP) cases and laboratory confirmation through isolation of poliovirus from stool. However, delayed sample collection and testing can delay outbreak detection. We investigated whether weekly testing for clusters of AFP by location and time, using the Kulldorff scan statistic, could provide an early warning for outbreaks in 20 countries. A mixed-effects regression model was used to predict background rates of nonpolio AFP at the district level. In Tajikistan and Congo, testing for AFP clusters would have resulted in an outbreak warning 39 and 11 days, respectively, before official confirmation of large outbreaks. This method has relatively high specificity and could be integrated into the current polio information system to support rapid outbreak response activities.

        Cite This Article
    EID Blake IM, Chenoweth P, Okayasu H, Donnelly CA, Aylward R, Grassly NC, et al. Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication. Emerg Infect Dis. 2016;22(3):449-456. https://dx.doi.org/10.3201/eid2203.151394
    AMA Blake IM, Chenoweth P, Okayasu H, et al. Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication. Emerging Infectious Diseases. 2016;22(3):449-456. doi:10.3201/eid2203.151394.
    APA Blake, I. M., Chenoweth, P., Okayasu, H., Donnelly, C. A., Aylward, R., & Grassly, N. C. (2016). Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication. Emerging Infectious Diseases, 22(3), 449-456. https://dx.doi.org/10.3201/eid2203.151394.
        Email Email this Article
  • Identification of Novel Zoonotic Activity of Bartonella spp., France PDF Version [PDF - 476 KB - 6 pages]
    M. Vayssier-Taussat et al.
    View Summary

    These bacteria may cause paucisymptomatic bacteremia and endocarditis in humans.

        View Abstract

    Certain Bartonella species are known to cause afebrile bacteremia in humans and other mammals, including B. quintana, the agent of trench fever, and B. henselae, the agent of cat scratch disease. Reports have indicated that animal-associated Bartonella species may cause paucisymptomatic bacteremia and endocarditis in humans. We identified potentially zoonotic strains from 6 Bartonella species in samples from patients who had chronic, subjective symptoms and who reported tick bites. Three strains were B. henselae and 3 were from other animal-associated Bartonella spp. (B. doshiae, B. schoenbuchensis, and B. tribocorum). Genomic analysis of the isolated strains revealed differences from previously sequenced Bartonella strains. Our investigation identifed 3 novel Bartonella spp. strains with human pathogenic potential and showed that Bartonella spp. may be the cause of undifferentiated chronic illness in humans who have been bitten by ticks.

        Cite This Article
    EID Vayssier-Taussat M, Moutailler S, Féménia F, Raymond P, Croce O, La Scola B, et al. Identification of Novel Zoonotic Activity of Bartonella spp., France. Emerg Infect Dis. 2016;22(3):457-462. https://dx.doi.org/10.3201/eid2203.150269
    AMA Vayssier-Taussat M, Moutailler S, Féménia F, et al. Identification of Novel Zoonotic Activity of Bartonella spp., France. Emerging Infectious Diseases. 2016;22(3):457-462. doi:10.3201/eid2203.150269.
    APA Vayssier-Taussat, M., Moutailler, S., Féménia, F., Raymond, P., Croce, O., La Scola, B....Raoult, D. (2016). Identification of Novel Zoonotic Activity of Bartonella spp., France. Emerging Infectious Diseases, 22(3), 457-462. https://dx.doi.org/10.3201/eid2203.150269.
        Email Email this Article
  • Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India PDF Version [PDF - 392 KB - 6 pages]
    K. L. Dierberg et al.
    View Summary

    The prevalence of TB is extremely high in this population and requires urgent attention.

        View Abstract

    The incidence of tuberculosis (TB) among Tibetan refugees in India is 431 cases/100,000 persons, compared with 181 cases/100,000 persons overall in India in 2010. More than half of TB cases in these refugees occur among students, monks, and nuns in congregate settings. We sought to increase TB case detection rates for this population through active case finding and rapid molecular diagnostics. We screened 27,714 persons for symptoms of TB and tested 3,830 symptomatic persons by using an algorithm incorporating chest radiography, sputum smear microscopy, culture, and a rapid diagnostic test; 96 (2.5%) cases of TB were detected (prevalence 346 cases/100,000 persons). Of these cases, 5% were multidrug-resistant TB. Use of the rapid diagnostic test and active case finding enabled rapid detection of undiagnosed TB cases in congregate living settings, which would not have otherwise been identified. The burden of TB in the Tibetan exile population in India is extremely high and requires urgent attention.

        Cite This Article
    EID Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerg Infect Dis. 2016;22(3):463-468. https://dx.doi.org/10.3201/eid2203.140732
    AMA Dierberg KL, Dorjee K, Salvo F, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerging Infectious Diseases. 2016;22(3):463-468. doi:10.3201/eid2203.140732.
    APA Dierberg, K. L., Dorjee, K., Salvo, F., Cronin, W. A., Boddy, J., Cirillo, D....Chaisson, R. E. (2016). Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerging Infectious Diseases, 22(3), 463-468. https://dx.doi.org/10.3201/eid2203.140732.
        Email Email this Article
  • Underestimation of Invasive Meningococcal Disease in Italy PDF Version [PDF - 520 KB - 7 pages]
    C. Azzari et al.
    View Summary

    Underestimation is attributable to misdiagnosis, especially in fatal cases, and use of insufficiently sensitive laboratory methods.

        View Abstract

    Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the number of cases misdiagnosed and diagnoses obtained postmortem with real-time PCR (rPCR), and we compared sensitivity of rPCR versus culture-based testing. A total of 222 IMD cases were identified: 11 (42%) of 26 fatal cases had been misdiagnosed or undiagnosed and were reclassified as IMD after rPCR showed meningococcal DNA in all available specimens taken postmortem. Of the samples tested with both rPCR and culture, 58% were diagnosed by using rPCR alone. The underestimation factor associated with the use of culture alone was 3.28. In countries such as Italy, where rPCR is in limited use, IMD incidence may be largely underestimated; thus, assessments of benefits of meningococcal vaccination may be prone to error.

        Cite This Article
    EID Azzari C, Nieddu F, Moriondo M, Indolfi G, Canessa C, Ricci S, et al. Underestimation of Invasive Meningococcal Disease in Italy. Emerg Infect Dis. 2016;22(3):469-475. https://dx.doi.org/10.3201/eid2203.150928
    AMA Azzari C, Nieddu F, Moriondo M, et al. Underestimation of Invasive Meningococcal Disease in Italy. Emerging Infectious Diseases. 2016;22(3):469-475. doi:10.3201/eid2203.150928.
    APA Azzari, C., Nieddu, F., Moriondo, M., Indolfi, G., Canessa, C., Ricci, S....Resti, M. (2016). Underestimation of Invasive Meningococcal Disease in Italy. Emerging Infectious Diseases, 22(3), 469-475. https://dx.doi.org/10.3201/eid2203.150928.
        Email Email this Article
  • Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections PDF Version [PDF - 399 KB - 6 pages]
    K. A. Etienne et al.
    View Summary

    Next-generation technologies and bioinformatics enabled source attribution and implementation of effective control strategies.

        View Abstract

    We used whole-genome sequence typing (WGST) to investigate an outbreak of Sarocladium kiliense bloodstream infections (BSI) associated with receipt of contaminated antinausea medication among oncology patients in Colombia and Chile during 2013–2014. Twenty-five outbreak isolates (18 from patients and 7 from medication vials) and 11 control isolates unrelated to this outbreak were subjected to WGST to elucidate a source of infection. All outbreak isolates were nearly indistinguishable (<5 single-nucleotide polymorphisms), and >21,000 single-nucleotide polymorphisms were identified from unrelated control isolates, suggesting a point source for this outbreak. S. kiliense has been previously implicated in healthcare-related infections; however, the lack of available typing methods has precluded the ability to substantiate point sources. WGST for outbreak investigation caused by eukaryotic pathogens without reference genomes or existing genotyping methods enables accurate source identification to guide implementation of appropriate control and prevention measures.

        Cite This Article
    EID Etienne KA, Roe CC, Smith R, Vallabhaneni S, Duarte C, Escandón P, et al. Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections. Emerg Infect Dis. 2016;22(3):476-481. https://dx.doi.org/10.3201/eid2203.151193
    AMA Etienne KA, Roe CC, Smith R, et al. Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections. Emerging Infectious Diseases. 2016;22(3):476-481. doi:10.3201/eid2203.151193.
    APA Etienne, K. A., Roe, C. C., Smith, R., Vallabhaneni, S., Duarte, C., Escandón, P....Litvintseva, A. P. (2016). Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections. Emerging Infectious Diseases, 22(3), 476-481. https://dx.doi.org/10.3201/eid2203.151193.
        Email Email this Article
  • Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia PDF Version [PDF - 1.86 MB - 9 pages]
    H. R. Stagg et al.
    View Summary

    This test decreased time to treatment initiation by 66%–84%.

        View Abstract

    Few studies have examined whether the Xpert MTB/RIF test improves time to treatment initiation for persons with multidrug-resistant tuberculosis (MDR TB). We determined the impact of this test in Latvia, where it was introduced in 2010. After descriptive analyses of pulmonary MDR TB patients in Latvia during 2009–2012, time to treatment initiation was calculated, and univariate and multivariable accelerated failure time models were constructed. Univariate results showed strong evidence of an association between having rifampin-resistant TB detected by Xpert MTB/RIF and reduced time to treatment initiation versus the test not being used. A multivariable model stratifying by previous TB showed similar results. Our finding that in Latvia, time to treatment initiation was decreased for MDR TB cases that were rifampin-resistant TB by XpertMTB/RIF has implications for the use of this test in other settings with a high burden of MDR TB in which rifampin resistance is highly predictive of MDR TB.

        Cite This Article
    EID Stagg HR, White PA, Riekstiņa V, Cīrule A, Šķenders Ģ, Leimane V, et al. Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia. Emerg Infect Dis. 2016;22(3):482-490. https://dx.doi.org/10.3201/eid2203.151227
    AMA Stagg HR, White PA, Riekstiņa V, et al. Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia. Emerging Infectious Diseases. 2016;22(3):482-490. doi:10.3201/eid2203.151227.
    APA Stagg, H. R., White, P. A., Riekstiņa, V., Cīrule, A., Šķenders, Ģ., Leimane, V....Jackson, C. (2016). Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia. Emerging Infectious Diseases, 22(3), 482-490. https://dx.doi.org/10.3201/eid2203.151227.
        Email Email this Article
  • Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014 PDF Version [PDF - 740 KB - 12 pages]
    T. E. Tupasi et al.
    View Summary

    Most commonly reported was medication side effects or fear of side effects.

        View Abstract

    To identify factors associated with loss to follow-up during treatment for multidrug-resistant (MDR) tuberculosis (TB) in the Philippines, we conducted a case–control study of adult patients who began receiving treatment for rifampin-resistant TB during July 1–December 31, 2012. Among 91 case-patients (those lost to follow-up) and 182 control-patients (those who adhered to treatment), independent factors associated with loss to follow-up included patients’ higher self-rating of the severity of vomiting as an adverse drug reaction and alcohol abuse. Protective factors included receiving any type of assistance from the TB program, better TB knowledge, and higher levels of trust in and support from physicians and nurses. These results provide insights for designing interventions aimed at reducing patient loss to follow-up during treatment for MDR TB.

        Cite This Article
    EID Tupasi TE, Garfin AG, Kurbatova EV, Mangan JM, Orillaza-Chi R, Naval LC, et al. Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491-502. https://dx.doi.org/10.3201/eid2203.151788
    AMA Tupasi TE, Garfin AG, Kurbatova EV, et al. Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014. Emerging Infectious Diseases. 2016;22(3):491-502. doi:10.3201/eid2203.151788.
    APA Tupasi, T. E., Garfin, A. G., Kurbatova, E. V., Mangan, J. M., Orillaza-Chi, R., Naval, L. C....Sarol, J. N. (2016). Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014. Emerging Infectious Diseases, 22(3), 491-502. https://dx.doi.org/10.3201/eid2203.151788.
        Email Email this Article
  • Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
                Email Email this Article

Dispatches

  • Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia PDF Version [PDF - 480 KB - 4 pages]
    N. F. Timchenko et al.
        View Abstract

    We used multivirulence locus sequence typing to analyze 68 Yersinia pseudotuberculosis isolated in Russia during 1973–2014, including 41 isolates from patients with Far East scarlet-like fever. Four genotypes were found responsible, with 1 being especially prevalent. Evolutionary analysis suggests that epidemiologic advantages could cause this genotype’s dominance.

        Cite This Article
    EID Timchenko NF, Adgamov RR, Popov AF, Psareva EK, Sobyanin KA, Gintsburg AL, et al. Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia. Emerg Infect Dis. 2016;22(3):503-506. https://dx.doi.org/10.3201/eid2203.150552
    AMA Timchenko NF, Adgamov RR, Popov AF, et al. Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia. Emerging Infectious Diseases. 2016;22(3):503-506. doi:10.3201/eid2203.150552.
    APA Timchenko, N. F., Adgamov, R. R., Popov, A. F., Psareva, E. K., Sobyanin, K. A., Gintsburg, A. L....Ermolaeva, S. A. (2016). Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia. Emerging Infectious Diseases, 22(3), 503-506. https://dx.doi.org/10.3201/eid2203.150552.
        Email Email this Article
  • Highly Pathogenic Avian Influenza A(H5N8) Viruses Reintroduced into South Korea by Migratory Waterfowl, 2014–2015 PDF Version [PDF - 416 KB - 4 pages]
    J. Kwon et al.
        View Abstract

    Highly pathogenic avian influenza A(H5N8) viruses were isolated from migratory waterfowl in South Korea during fall 2014–winter 2015, a recurrence after initial introduction in winter 2014. These reappeared viruses were phylogenetically distinct from isolates circulating in poultry farms in South Korea.

        Cite This Article
    EID Kwon J, Lee D, Swayne DE, Noh J, Yuk S, Erdene-Ochir T, et al. Highly Pathogenic Avian Influenza A(H5N8) Viruses Reintroduced into South Korea by Migratory Waterfowl, 2014–2015. Emerg Infect Dis. 2016;22(3):507-510. https://dx.doi.org/10.3201/eid2203.151006
    AMA Kwon J, Lee D, Swayne DE, et al. Highly Pathogenic Avian Influenza A(H5N8) Viruses Reintroduced into South Korea by Migratory Waterfowl, 2014–2015. Emerging Infectious Diseases. 2016;22(3):507-510. doi:10.3201/eid2203.151006.
    APA Kwon, J., Lee, D., Swayne, D. E., Noh, J., Yuk, S., Erdene-Ochir, T....Song, C. (2016). Highly Pathogenic Avian Influenza A(H5N8) Viruses Reintroduced into South Korea by Migratory Waterfowl, 2014–2015. Emerging Infectious Diseases, 22(3), 507-510. https://dx.doi.org/10.3201/eid2203.151006.
        Email Email this Article
  • Treatment of Mycobacterium abscessus Infection PDF Version [PDF - 395 KB - 4 pages]
    S. A. Novosad et al.
        View Abstract

    Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.

        Cite This Article
    EID Novosad SA, Beekmann SE, Polgreen PM, Mackey K, Winthrop KL. Treatment of Mycobacterium abscessus Infection. Emerg Infect Dis. 2016;22(3):511-514. https://dx.doi.org/10.3201/eid2203.150828
    AMA Novosad SA, Beekmann SE, Polgreen PM, et al. Treatment of Mycobacterium abscessus Infection. Emerging Infectious Diseases. 2016;22(3):511-514. doi:10.3201/eid2203.150828.
    APA Novosad, S. A., Beekmann, S. E., Polgreen, P. M., Mackey, K., & Winthrop, K. L. (2016). Treatment of Mycobacterium abscessus Infection. Emerging Infectious Diseases, 22(3), 511-514. https://dx.doi.org/10.3201/eid2203.150828.
        Email Email this Article
  • Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013 PDF Version [PDF - 345 KB - 3 pages]
    A. Malik et al.
        View Abstract

    As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin–peginterferon-α therapy.

        Cite This Article
    EID Malik A, El Masry K, Ravi M, Sayed F. Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerg Infect Dis. 2016;22(3):515-517. https://dx.doi.org/10.3201/eid2203.151049
    AMA Malik A, El Masry K, Ravi M, et al. Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerging Infectious Diseases. 2016;22(3):515-517. doi:10.3201/eid2203.151049.
    APA Malik, A., El Masry, K., Ravi, M., & Sayed, F. (2016). Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerging Infectious Diseases, 22(3), 515-517. https://dx.doi.org/10.3201/eid2203.151049.
        Email Email this Article
  • Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014 PDF Version [PDF - 434 KB - 4 pages]
    B. Henry et al.
        View Abstract

    We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation.

        Cite This Article
    EID Henry B, Revest M, Dournon N, Epelboin L, Mellon G, Bellaud G, et al. Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerg Infect Dis. 2016;22(3):518-521. https://dx.doi.org/10.3201/eid2203.151130
    AMA Henry B, Revest M, Dournon N, et al. Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerging Infectious Diseases. 2016;22(3):518-521. doi:10.3201/eid2203.151130.
    APA Henry, B., Revest, M., Dournon, N., Epelboin, L., Mellon, G., Bellaud, G....Caumes, É. (2016). Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerging Infectious Diseases, 22(3), 518-521. https://dx.doi.org/10.3201/eid2203.151130.
        Email Email this Article
  • Lyme Disease in Hispanics, United States, 2000–2013 PDF Version [PDF - 397 KB - 4 pages]
    C. A. Nelson et al.
        View Abstract

    Hispanics comprise a growing portion of the US population and might have distinct risk factors for tickborne diseases. During 2000–2013, a total of 5,473 Lyme disease cases were reported among Hispanics through national surveillance. Hispanics were more likely than non-Hispanics to have signs of disseminated infection and onset during fall months.

        Cite This Article
    EID Nelson CA, Starr J, Kugeler KJ, Mead PS. Lyme Disease in Hispanics, United States, 2000–2013. Emerg Infect Dis. 2016;22(3):522-525. https://dx.doi.org/10.3201/eid2203.151273
    AMA Nelson CA, Starr J, Kugeler KJ, et al. Lyme Disease in Hispanics, United States, 2000–2013. Emerging Infectious Diseases. 2016;22(3):522-525. doi:10.3201/eid2203.151273.
    APA Nelson, C. A., Starr, J., Kugeler, K. J., & Mead, P. S. (2016). Lyme Disease in Hispanics, United States, 2000–2013. Emerging Infectious Diseases, 22(3), 522-525. https://dx.doi.org/10.3201/eid2203.151273.
        Email Email this Article
  • Association between Severity of MERS-CoV Infection and Incubation Period PDF Version [PDF - 314 KB - 3 pages]
    V. Virlogeux et al.
        View Abstract

    We analyzed data for 170 patients in South Korea who had laboratory-confirmed infection with Middle East respiratory syndrome coronavirus. A longer incubation period was associated with a reduction in the risk for death (adjusted odds ratio/1-day increase in incubation period 0.83, 95% credibility interval 0.68–1.03).

        Cite This Article
    EID Virlogeux V, Park M, Wu JT, Cowling BJ. Association between Severity of MERS-CoV Infection and Incubation Period. Emerg Infect Dis. 2016;22(3):526-528. https://dx.doi.org/10.3201/eid2203.151437
    AMA Virlogeux V, Park M, Wu JT, et al. Association between Severity of MERS-CoV Infection and Incubation Period. Emerging Infectious Diseases. 2016;22(3):526-528. doi:10.3201/eid2203.151437.
    APA Virlogeux, V., Park, M., Wu, J. T., & Cowling, B. J. (2016). Association between Severity of MERS-CoV Infection and Incubation Period. Emerging Infectious Diseases, 22(3), 526-528. https://dx.doi.org/10.3201/eid2203.151437.
        Email Email this Article
  • Liver Abscess Caused by Infection with Community-Acquired Klebsiella quasipneumoniae subsp. quasipneumoniae PDF Version [PDF - 444 KB - 3 pages]
    S. Breurec et al.
        View Abstract

    We report a case of pyogenic liver abscess caused by community-acquired Klebsiella quasipneumoniae subsp. quasipneumoniae. The infecting isolate had 2 prominent features of hypervirulent K. pneumoniae strains: the capsular polysaccharide synthesis region for K1 serotype and the integrative and conjugative element ICEKp1, which encodes the virulence factors yersiniabactin, salmochelin, and RmpA.

        Cite This Article
    EID Breurec S, Melot B, Hoen B, Passet V, Schepers K, Bastian S, et al. Liver Abscess Caused by Infection with Community-Acquired Klebsiella quasipneumoniae subsp. quasipneumoniae. Emerg Infect Dis. 2016;22(3):529-531. https://dx.doi.org/10.3201/eid2203.151466
    AMA Breurec S, Melot B, Hoen B, et al. Liver Abscess Caused by Infection with Community-Acquired Klebsiella quasipneumoniae subsp. quasipneumoniae. Emerging Infectious Diseases. 2016;22(3):529-531. doi:10.3201/eid2203.151466.
    APA Breurec, S., Melot, B., Hoen, B., Passet, V., Schepers, K., Bastian, S....Brisse, S. (2016). Liver Abscess Caused by Infection with Community-Acquired Klebsiella quasipneumoniae subsp. quasipneumoniae. Emerging Infectious Diseases, 22(3), 529-531. https://dx.doi.org/10.3201/eid2203.151466.
        Email Email this Article
  • Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening PDF Version [PDF - 317 KB - 3 pages]
    M. Hoenigl et al.
        View Abstract

    We analyzed signs and symptoms in 90 patients diagnosed with acute HIV infection in a community-based program that offered universal HIV-1 nucleic acid amplification testing. Forty-seven (52%) patients reported ongoing signs or symptoms at the time of testing. Another 25 (28%) reported signs or symptoms that had occurred during the 14 days before testing.

        Cite This Article
    EID Hoenigl M, Green N, Camacho M, Gianella S, Mehta SR, Smith DM, et al. Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening. Emerg Infect Dis. 2016;22(3):532-534. https://dx.doi.org/10.3201/eid2203.151607
    AMA Hoenigl M, Green N, Camacho M, et al. Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening. Emerging Infectious Diseases. 2016;22(3):532-534. doi:10.3201/eid2203.151607.
    APA Hoenigl, M., Green, N., Camacho, M., Gianella, S., Mehta, S. R., Smith, D. M....Little, S. J. (2016). Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening. Emerging Infectious Diseases, 22(3), 532-534. https://dx.doi.org/10.3201/eid2203.151607.
        Email Email this Article
  • Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa PDF Version [PDF - 339 KB - 3 pages]
    M. M. Claassens et al.
        View Abstract

    To address the uncertainty of the indirectly measured tuberculosis case detection rate, we used survey data stratified by HIV status to calculate the patient diagnostic rate, a directly measurable indicator, in 8 communities in South Africa. Rates were lower among HIV-negative than HIV-positive persons. Tuberculosis programs should focus on HIV-negative persons.

        Cite This Article
    EID Claassens MM, van Schalkwyk C, Dunbar R, Ayles H, Beyers N. Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa. Emerg Infect Dis. 2016;22(3):535-537. https://dx.doi.org/10.3201/eid2203.151618
    AMA Claassens MM, van Schalkwyk C, Dunbar R, et al. Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa. Emerging Infectious Diseases. 2016;22(3):535-537. doi:10.3201/eid2203.151618.
    APA Claassens, M. M., van Schalkwyk, C., Dunbar, R., Ayles, H., & Beyers, N. (2016). Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa. Emerging Infectious Diseases, 22(3), 535-537. https://dx.doi.org/10.3201/eid2203.151618.
        Email Email this Article
  • Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices PDF Version [PDF - 322 KB - 3 pages]
    A. Story et al.
        View Abstract

    A recent innovation to help patients adhere to daily tuberculosis (TB) treatment over many months is video (or virtually) observed therapy (VOT). VOT is becoming increasingly feasible as mobile telephone applications and tablet computers become more widely available. Studies of the effectiveness of VOT in improving TB patient outcomes are being conducted.

        Cite This Article
    EID Story A, Garfein RS, Hayward A, Rusovich V, Dadu A, Soltan V, et al. Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerg Infect Dis. 2016;22(3):538-540. https://dx.doi.org/10.3201/eid2203.151620
    AMA Story A, Garfein RS, Hayward A, et al. Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerging Infectious Diseases. 2016;22(3):538-540. doi:10.3201/eid2203.151620.
    APA Story, A., Garfein, R. S., Hayward, A., Rusovich, V., Dadu, A., Soltan, V....Falzon, D. (2016). Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerging Infectious Diseases, 22(3), 538-540. https://dx.doi.org/10.3201/eid2203.151620.
        Email Email this Article
  • Tuberculosis Risk among Medical Trainees, Pune, India PDF Version [PDF - 349 KB - 3 pages]
    A. Basavaraj et al.
        View Abstract

    During 2012–2013, at a public hospital in Pune, India, 26 (3.9%) cases of tuberculosis were reported among 662 medical trainees, representing an estimated incidence of 3,279 cases/100,000 person-years. Three of these infections were isoniazid-resistant, 1 was multidrug-resistant, and 1 occurred in a trainee who had fulminant hepatitis after starting treatment for TB.

        Cite This Article
    EID Basavaraj A, Chandanwale A, Patil A, Kadam D, Joshi S, Gupte N, et al. Tuberculosis Risk among Medical Trainees, Pune, India. Emerg Infect Dis. 2016;22(3):541-543. https://dx.doi.org/10.3201/eid2203.151673
    AMA Basavaraj A, Chandanwale A, Patil A, et al. Tuberculosis Risk among Medical Trainees, Pune, India. Emerging Infectious Diseases. 2016;22(3):541-543. doi:10.3201/eid2203.151673.
    APA Basavaraj, A., Chandanwale, A., Patil, A., Kadam, D., Joshi, S., Gupte, N....Mave, V. (2016). Tuberculosis Risk among Medical Trainees, Pune, India. Emerging Infectious Diseases, 22(3), 541-543. https://dx.doi.org/10.3201/eid2203.151673.
        Email Email this Article
  • Human Lymphadenopathy Caused by Ratborne Bartonella, Tbilisi, Georgia PDF Version [PDF - 352 KB - 3 pages]
    G. Kandelaki et al.
        View Abstract

    Lymphadenopathy and fever that developed in a woman in Tbilisi, Georgia, most likely were caused by a ratborne Bartonella strain related B. tribocorum and B. elizabethae. The finding suggests that this Bartonella strain could be spread by infected rats and represents a potential human risk.

        Cite This Article
    EID Kandelaki G, Malania L, Bai Y, Chakvetadze N, Katsitadze G, Imnadze P, et al. Human Lymphadenopathy Caused by Ratborne Bartonella, Tbilisi, Georgia. Emerg Infect Dis. 2016;22(3):544-546. https://dx.doi.org/10.3201/eid2203.151823
    AMA Kandelaki G, Malania L, Bai Y, et al. Human Lymphadenopathy Caused by Ratborne Bartonella, Tbilisi, Georgia. Emerging Infectious Diseases. 2016;22(3):544-546. doi:10.3201/eid2203.151823.
    APA Kandelaki, G., Malania, L., Bai, Y., Chakvetadze, N., Katsitadze, G., Imnadze, P....Kosoy, M. Y. (2016). Human Lymphadenopathy Caused by Ratborne Bartonella, Tbilisi, Georgia. Emerging Infectious Diseases, 22(3), 544-546. https://dx.doi.org/10.3201/eid2203.151823.
        Email Email this Article
  • Tuberculosis, Fiji, 2002–2013 PDF Version [PDF - 378 KB - 3 pages]
    L. Pezzoli et al.
        View Abstract

    During 2002–2013, a total of 1,890 tuberculosis cases were recorded in Fiji. Notification rates per 100,000 population increased from 17.4 cases in 2002 to 28.4 in 2013. Older persons were most affected, but tuberculosis also increased sharply in persons 25–44 years of age.

        Cite This Article
    EID Pezzoli L, Gounder S, Tamani T, Daulako M, Underwood F, Mainawalala S, et al. Tuberculosis, Fiji, 2002–2013. Emerg Infect Dis. 2016;22(3):547-549. https://dx.doi.org/10.3201/eid2203.151903
    AMA Pezzoli L, Gounder S, Tamani T, et al. Tuberculosis, Fiji, 2002–2013. Emerging Infectious Diseases. 2016;22(3):547-549. doi:10.3201/eid2203.151903.
    APA Pezzoli, L., Gounder, S., Tamani, T., Daulako, M., Underwood, F., Mainawalala, S....Gillini, L. (2016). Tuberculosis, Fiji, 2002–2013. Emerging Infectious Diseases, 22(3), 547-549. https://dx.doi.org/10.3201/eid2203.151903.
        Email Email this Article

Letters

  • Borrelia miyamotoi and Candidatus Neoehrlichia mikurensis in Ixodes ricinus Ticks, Romania PDF Version [PDF - 354 KB - 2 pages]
    Z. Kalmár et al.
            Cite This Article
    EID Kalmár Z, Sprong H, Mihalca AD, Gherman CM, Dumitrache MO, Coipan EC, et al. Borrelia miyamotoi and Candidatus Neoehrlichia mikurensis in Ixodes ricinus Ticks, Romania. Emerg Infect Dis. 2016;22(3):550-551. https://dx.doi.org/10.3201/eid2203.150140
    AMA Kalmár Z, Sprong H, Mihalca AD, et al. Borrelia miyamotoi and Candidatus Neoehrlichia mikurensis in Ixodes ricinus Ticks, Romania. Emerging Infectious Diseases. 2016;22(3):550-551. doi:10.3201/eid2203.150140.
    APA Kalmár, Z., Sprong, H., Mihalca, A. D., Gherman, C. M., Dumitrache, M. O., Coipan, E. C....Cozma, V. (2016). Borrelia miyamotoi and Candidatus Neoehrlichia mikurensis in Ixodes ricinus Ticks, Romania. Emerging Infectious Diseases, 22(3), 550-551. https://dx.doi.org/10.3201/eid2203.150140.
        Email Email this Article
  • Suspected Rabies in Humans and Animals, Laikipia County, Kenya PDF Version [PDF - 344 KB - 3 pages]
    M. Obonyo et al.
            Cite This Article
    EID Obonyo M, Akoko JM, Orinde AB, Osoro E, Boru W, Njeru I, et al. Suspected Rabies in Humans and Animals, Laikipia County, Kenya. Emerg Infect Dis. 2016;22(3):551-553. https://dx.doi.org/10.3201/eid2203.151118
    AMA Obonyo M, Akoko JM, Orinde AB, et al. Suspected Rabies in Humans and Animals, Laikipia County, Kenya. Emerging Infectious Diseases. 2016;22(3):551-553. doi:10.3201/eid2203.151118.
    APA Obonyo, M., Akoko, J. M., Orinde, A. B., Osoro, E., Boru, W., Njeru, I....Fèvre, E. M. (2016). Suspected Rabies in Humans and Animals, Laikipia County, Kenya. Emerging Infectious Diseases, 22(3), 551-553. https://dx.doi.org/10.3201/eid2203.151118.
        Email Email this Article
  • Generalized Cowpox Virus Infection in a Patient with HIV, Germany, 2012 PDF Version [PDF - 377 KB - 3 pages]
    P. Fassbender et al.
            Cite This Article
    EID Fassbender P, Zange S, Ibrahim S, Zoeller G, Herbstreit F, Meyer H, et al. Generalized Cowpox Virus Infection in a Patient with HIV, Germany, 2012. Emerg Infect Dis. 2016;22(3):553-555. https://dx.doi.org/10.3201/eid2203.151158
    AMA Fassbender P, Zange S, Ibrahim S, et al. Generalized Cowpox Virus Infection in a Patient with HIV, Germany, 2012. Emerging Infectious Diseases. 2016;22(3):553-555. doi:10.3201/eid2203.151158.
    APA Fassbender, P., Zange, S., Ibrahim, S., Zoeller, G., Herbstreit, F., & Meyer, H. (2016). Generalized Cowpox Virus Infection in a Patient with HIV, Germany, 2012. Emerging Infectious Diseases, 22(3), 553-555. https://dx.doi.org/10.3201/eid2203.151158.
        Email Email this Article
  • Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015 PDF Version [PDF - 468 KB - 3 pages]
    E. Miguel et al.
            Cite This Article
    EID Miguel E, Perera R, Baubekova A, Chevalier V, Faye B, Akhmetsadykov N, et al. Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015. Emerg Infect Dis. 2016;22(3):555-557. https://dx.doi.org/10.3201/eid2203.151284
    AMA Miguel E, Perera R, Baubekova A, et al. Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015. Emerging Infectious Diseases. 2016;22(3):555-557. doi:10.3201/eid2203.151284.
    APA Miguel, E., Perera, R., Baubekova, A., Chevalier, V., Faye, B., Akhmetsadykov, N....Oh, M. (2016). Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015. Emerging Infectious Diseases, 22(3), 555-557. https://dx.doi.org/10.3201/eid2203.151284.
        Email Email this Article
  • Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014 PDF Version [PDF - 369 KB - 3 pages]
    I. Takayama et al.
            Cite This Article
    EID Takayama I, Hieu N, Shirakura M, Nakauchi M, Fujisaki S, Takahashi H, et al. Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014. Emerg Infect Dis. 2016;22(3):557-559. https://dx.doi.org/10.3201/eid2203.151360
    AMA Takayama I, Hieu N, Shirakura M, et al. Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014. Emerging Infectious Diseases. 2016;22(3):557-559. doi:10.3201/eid2203.151360.
    APA Takayama, I., Hieu, N., Shirakura, M., Nakauchi, M., Fujisaki, S., Takahashi, H....Kageyama, T. (2016). Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014. Emerging Infectious Diseases, 22(3), 557-559. https://dx.doi.org/10.3201/eid2203.151360.
        Email Email this Article
  • Mycobacterium arupense as an Emerging Cause of Tenosynovitis PDF Version [PDF - 352 KB - 3 pages]
    F. Lopez et al.
            Cite This Article
    EID Lopez F, Miley M, Taiwo B. Mycobacterium arupense as an Emerging Cause of Tenosynovitis. Emerg Infect Dis. 2016;22(3):559-561. https://dx.doi.org/10.3201/eid2203.151479
    AMA Lopez F, Miley M, Taiwo B. Mycobacterium arupense as an Emerging Cause of Tenosynovitis. Emerging Infectious Diseases. 2016;22(3):559-561. doi:10.3201/eid2203.151479.
    APA Lopez, F., Miley, M., & Taiwo, B. (2016). Mycobacterium arupense as an Emerging Cause of Tenosynovitis. Emerging Infectious Diseases, 22(3), 559-561. https://dx.doi.org/10.3201/eid2203.151479.
        Email Email this Article
  • Candida haemulonii Complex Species, Brazil, January 2010–March 2015 PDF Version [PDF - 355 KB - 3 pages]
    J. Nobrega de Almeida et al.
            Cite This Article
    EID Nobrega de Almeida J, Assy J, Levin AS, Del Negro G, Giudice MC, Tringoni M, et al. Candida haemulonii Complex Species, Brazil, January 2010–March 2015. Emerg Infect Dis. 2016;22(3):561-563. https://dx.doi.org/10.3201/eid2203.151610
    AMA Nobrega de Almeida J, Assy J, Levin AS, et al. Candida haemulonii Complex Species, Brazil, January 2010–March 2015. Emerging Infectious Diseases. 2016;22(3):561-563. doi:10.3201/eid2203.151610.
    APA Nobrega de Almeida, J., Assy, J., Levin, A. S., Del Negro, G., Giudice, M. C., Tringoni, M....Benard, G. (2016). Candida haemulonii Complex Species, Brazil, January 2010–March 2015. Emerging Infectious Diseases, 22(3), 561-563. https://dx.doi.org/10.3201/eid2203.151610.
        Email Email this Article
  • Review of Cases and a Patient Report of Myiasis with Tracheostomy, Peru PDF Version [PDF - 344 KB - 3 pages]
    V. E. Failoc-Rojas and H. Silva-Díaz
            Cite This Article
    EID Failoc-Rojas VE, Silva-Díaz H. Review of Cases and a Patient Report of Myiasis with Tracheostomy, Peru. Emerg Infect Dis. 2016;22(3):563-565. https://dx.doi.org/10.3201/eid2203.151631
    AMA Failoc-Rojas VE, Silva-Díaz H. Review of Cases and a Patient Report of Myiasis with Tracheostomy, Peru. Emerging Infectious Diseases. 2016;22(3):563-565. doi:10.3201/eid2203.151631.
    APA Failoc-Rojas, V. E., & Silva-Díaz, H. (2016). Review of Cases and a Patient Report of Myiasis with Tracheostomy, Peru. Emerging Infectious Diseases, 22(3), 563-565. https://dx.doi.org/10.3201/eid2203.151631.
        Email Email this Article
  • Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States PDF Version [PDF - 333 KB - 3 pages]
    R. B. Perumpail et al.
            Cite This Article
    EID Perumpail RB, Wong RJ, Liu A, Jayasekera CR, Dieterich DT, Younossi ZM, et al. Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States. Emerg Infect Dis. 2016;22(3):565-567. https://dx.doi.org/10.3201/eid2203.151650
    AMA Perumpail RB, Wong RJ, Liu A, et al. Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States. Emerging Infectious Diseases. 2016;22(3):565-567. doi:10.3201/eid2203.151650.
    APA Perumpail, R. B., Wong, R. J., Liu, A., Jayasekera, C. R., Dieterich, D. T., Younossi, Z. M....Ahmed, A. (2016). Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States. Emerging Infectious Diseases, 22(3), 565-567. https://dx.doi.org/10.3201/eid2203.151650.
        Email Email this Article
  • Wohlfahrtiimonas chitiniclastica Infections in 2 Elderly Patients, Hawaii, USA PDF Version [PDF - 332 KB - 2 pages]
    M. Nogi et al.
            Cite This Article
    EID Nogi M, Bankowski MJ, Pien FD. Wohlfahrtiimonas chitiniclastica Infections in 2 Elderly Patients, Hawaii, USA. Emerg Infect Dis. 2016;22(3):567-568. https://dx.doi.org/10.3201/eid2203.151701
    AMA Nogi M, Bankowski MJ, Pien FD. Wohlfahrtiimonas chitiniclastica Infections in 2 Elderly Patients, Hawaii, USA. Emerging Infectious Diseases. 2016;22(3):567-568. doi:10.3201/eid2203.151701.
    APA Nogi, M., Bankowski, M. J., & Pien, F. D. (2016). Wohlfahrtiimonas chitiniclastica Infections in 2 Elderly Patients, Hawaii, USA. Emerging Infectious Diseases, 22(3), 567-568. https://dx.doi.org/10.3201/eid2203.151701.
        Email Email this Article
  • Mycobacterium microti Infection in Dairy Goats, France PDF Version [PDF - 352 KB - 2 pages]
    L. Michelet et al.
            Cite This Article
    EID Michelet L, de Cruz K, Phalente Y, Karoui C, Hénault S, Beral M, et al. Mycobacterium microti Infection in Dairy Goats, France. Emerg Infect Dis. 2016;22(3):569-570. https://dx.doi.org/10.3201/eid2203.151870
    AMA Michelet L, de Cruz K, Phalente Y, et al. Mycobacterium microti Infection in Dairy Goats, France. Emerging Infectious Diseases. 2016;22(3):569-570. doi:10.3201/eid2203.151870.
    APA Michelet, L., de Cruz, K., Phalente, Y., Karoui, C., Hénault, S., Beral, M....Boschiroli, M. L. (2016). Mycobacterium microti Infection in Dairy Goats, France. Emerging Infectious Diseases, 22(3), 569-570. https://dx.doi.org/10.3201/eid2203.151870.
        Email Email this Article
  • Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015 PDF Version [PDF - 426 KB - 3 pages]
    J. Thapa et al.
            Cite This Article
    EID Thapa J, Paudel S, Sadaula A, Shah Y, Maharjan B, Kaufman GE, et al. Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015. Emerg Infect Dis. 2016;22(3):570-572. https://dx.doi.org/10.3201/eid2203.151929
    AMA Thapa J, Paudel S, Sadaula A, et al. Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015. Emerging Infectious Diseases. 2016;22(3):570-572. doi:10.3201/eid2203.151929.
    APA Thapa, J., Paudel, S., Sadaula, A., Shah, Y., Maharjan, B., Kaufman, G. E....Nakajima, C. (2016). Mycobacterium orygis–Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015. Emerging Infectious Diseases, 22(3), 570-572. https://dx.doi.org/10.3201/eid2203.151929.
        Email Email this Article

About the Cover

  • Depictions of Heroism in Battle and Anguish from Tuberculosis PDF Version [PDF - 332 KB - 2 pages]
    T. Chorba and B. Breedlove
            Cite This Article
    EID Chorba T, Breedlove B. Depictions of Heroism in Battle and Anguish from Tuberculosis. Emerg Infect Dis. 2016;22(3):573-574. https://dx.doi.org/10.3201/eid2203.AC2203
    AMA Chorba T, Breedlove B. Depictions of Heroism in Battle and Anguish from Tuberculosis. Emerging Infectious Diseases. 2016;22(3):573-574. doi:10.3201/eid2203.AC2203.
    APA Chorba, T., & Breedlove, B. (2016). Depictions of Heroism in Battle and Anguish from Tuberculosis. Emerging Infectious Diseases, 22(3), 573-574. https://dx.doi.org/10.3201/eid2203.AC2203.
        Email Email this Article

Etymologia

Online Reports

  • Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
    T. Sullivan and Y. Ben Amor
        View Abstract

    New treatments for multidrug-resistant tuberculosis (MDR TB) are urgently needed. Two new drugs, bedaquiline and delamanid, have recently been released, and several new drugs and treatment regimens are in the pipeline. Misuse of TB drugs is a principal cause of drug resistance. As new drugs and regimens reach the market, the need to make them available to patients must be balanced with regulation of their use so that resistance to the new drugs can be prevented. To foster the rational use of new drugs, we propose 1) expanding/strengthening the capacity for drug susceptibility testing, beginning with countries with a high TB burden; 2) regulating prescribing practices by banning over-the-counter sale of TB drugs and enacting an accreditation system whereby providers must be certified to prescribe new drugs; and 3) decentralizing MDR TB care in rural communities by employing trained community health workers, using promising mobile technologies, and enlisting the aid of civil society organizations.

            Email Email this Article
  • Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
    J. Furin et al.
        View Abstract

    Two new drugs—bedaquiline and delamanid—have recently been approved by stringent regulatory authorities to treat multidrug-resistant tuberculosis (TB) and recommended by the World Health Organization for use under defined programmatic conditions. Introducing the medications in TB programs worldwide has not kept pace with the need for these drugs. In response, the DR-TB STAT (Drug-Resistant TB Scale-up Treatment Action Team) task force was formed in April 2015 to monitor progress and help overcome challenges. Information was collected from multiple sources and assessed monthly. Some progress has been made in introducing bedaquiline: as of October 2015, a total of 1,258 persons were on the medication under programmatic conditions. For delamanid, >100 patients, but few under programmatic conditions, have received the medication. Coordinated global action might help assist making these medications accessible for persons who need them most.

            Email Email this Article
TOP